Identification of a dysfibrinogenemia of γR275C (Fibrinogen Fukushima)

Clinica Chimica Acta

Volumn 325, Issue 1-2, 2002, Pages 151-156

  Imafuku, Yuji ^a   Tanaka, Kyoko ^a   Takahashi, Kiyoaki ^a   Ogawa, Kazuei ^a   Sanpei, Minoru ^a   Yamada, Hidekazu ^a   Sato, Akira ^a   Yoshida, Hiroshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

R275C; Coagulation test; DNA sequencing; Dysfibrinogenemia; Immunoblotting; Thrombin time

Indexed keywords

BATROXOBIN; CALCIUM ION; FIBRINOGEN VARIANT; GENOMIC DNA; THROMBIN; CALCIUM; FIBRINOGEN FUKUSHIMA;

ADULT; ARTICLE; CALCULATION; CASE REPORT; CATTLE; CLINICAL FEATURE; DNA DETERMINATION; DNA EXTRACTION; DNA SEQUENCE; DYSFIBRINOGENEMIA; FAMILY HISTORY; FEMALE; FIBRINOGEN BLOOD LEVEL; GENE IDENTIFICATION; GENE MUTATION; HOSPITAL ADMISSION; HUMAN; IMMUNOASSAY; MALE; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBIN TIME; FAMILY HEALTH; GENETICS; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PEDIGREE; PHENOTYPE; REVIEW;

BOVINAE;

ADULT; CALCIUM; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; FIBRINOGENS, ABNORMAL; HUMANS; MUTATION, MISSENSE; PEDIGREE; PHENOTYPE; PREGNANCY; THROMBIN TIME;

EID: 0036843962     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00293-0     Document Type: Article

References (18)

1. Martinez J. Quantitative and qualitative disorders of fibrinogen. Hoffman R.et al. Hematology. 3rd Ed. 2000;1924-1936 Churchill Livingstone, New York.
2. http://www.geht.org/pages/database_fibrino_uk.html.
3. Terasawa F., Fujita K., Tozuka M., Ota H., Katsuyama T., Okumura N. Identification of a dysfibrinogen, the substitution of γ308Asn (AAT) to Lys (AAG), using coagulation tests, immunoblot analysis, and allele-specific polymerase chain reaction. Clin. Chim. Acta. 295:2000;77-85.
4. Matsuda M., Baba M., Morimoto K., Nakamikawa K. Fibrinogen Tokyo II: an abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules. J. Clin. Invest. 72:1983;1034-1041.
5. Schmelzer C.H., Ebert R.F., Bell W.R. Fibrinogen Baltimore IV: congenital dysfibrinogenemia with a γ275 (Arg→Cys) substitution. Thromb. Res. 56:1989;307-316.
6. Terukina S., Matsuda M., Yoshida N., Yamazaki N., Takeda Y., Takano T. Two abnormal fibrinogens designated as Osaka II and Morioka with a hitherto unidentified amino acid substitution; γ Arg 275 by Cys. Thromb. Haemost. 58:1987;515. [abstract].
7. Yoshida N., Ota K., Moroi M., Matsuda M. An apparently higher molecular weight γ-chain variant in a new congenital abnormal fibrinogen Tochigi characterized by the replacement of γ arginine-275 by cysteine. Blood. 71:1988;480-487.
8. Terukina S., Matsuda M., Hirata H.et al. Substitution of γ Arg-275 by Cys in an abnormal fibrinogen, "Fibrinogen Osaka II" J. Biol. Chem. 263:1988;13579-13587.
9. Steinmann C., Bögli C., Jungo M.et al. Fibrinogen Milano V: a congenital dysfibrinogenemia with a γ275→Cys substitution. Blood Coagul. Fibrinolysis. 5:1994;463-471.
10. Borrell M., Garí M., Coll I.et al. Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinogenaemias: Barcelona III and IV (γArg275→His) and Villajoyosa (γArg275→Cys). Blood Coagul. Fibrinolysis. 6:1995;198-206.
11. Haverkate F., Samama M. Familial dysfibrinogenemia and thrombophilia. Thromb. Haemost. 73:1995;151-161.
12. Terasawa F., Okumura N., Higuchi Y.et al. Fibrinogen Matsumoto III: a variant with γ275 Arg→Cys (CGC→TGC)-comparison of fibrin polymerization properties with those of Matsumoto I (γ364 Asp→His) and Matsumoto II (γ308 Asn→Lys). Thromb. Haemost. 81:1999;763-766.
13. Linenberger M.L., Kindelan J., Bennett R.L., Reiner A.P., Côté H.C.F. Fibrinogen Bellingham: a γ-chain R275C substitution and a β-promoter polymorphism in a thrombotic member of an asymptomatic family. Am. J. Hematol. 64:2000;242-250.
14. Siebenlist K.R., Mosesson M.W., Meh D.A., DiOrio J.P., Albrecht R.M., Olson J.D. Coexisting dysfibrinogenemia (γR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids). Blood Coagul. Fibrinolysis. 11:2000;293-304.
15. Belitser V.A., Varetskaja T.V., Malneva G.V. Fibrinogen-fibrin interaction. Biochim. Biophys. Acta. 154:1968;367-375.
16. Côté H.C.F., Lord S.T., Pratt K.P. γ-chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the γ-chain of human fibrinogen. Blood. 92:1998;2195-2212.
17. Spraggon G., Everse S.J., Doolitle R.F. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature. 389:1997;455-462.
18. Everse S.J., Spraggon G., Veerapandian L., Marcia R., Doolittle R.F. Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry. 37:1998;8637-8642.